234 related articles for article (PubMed ID: 11585385)
21. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
Bright JJ; Sriram S
J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
23. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
24. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
25. Vanadate enhances leptin-induced activation of JAK/STAT pathway in CHO cells.
Kita A; Uotani S; Kuwahara H; Takahashi R; Oshima K; Yamasaki H; Mizuguchi H; Hayakawa T; Nagayama Y; Yamaguchi Y; Eguchi K
Biochem Biophys Res Commun; 2003 Mar; 302(4):805-9. PubMed ID: 12646241
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
27. Leptin signaling in the hypothalamus during chronic central leptin infusion.
Pal R; Sahu A
Endocrinology; 2003 Sep; 144(9):3789-98. PubMed ID: 12933650
[TBL] [Abstract][Full Text] [Related]
28. Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients.
Najib S; Rodríguez-Baño J; Ríos MJ; Muniain MA; Goberna R; Sánchez-Margalet V
Clin Exp Immunol; 2005 Sep; 141(3):518-25. PubMed ID: 16045742
[TBL] [Abstract][Full Text] [Related]
29. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism.
Deo DD; Axelrad TW; Robert EG; Marcheselli V; Bazan NG; Hunt JD
J Biol Chem; 2002 Jun; 277(24):21237-45. PubMed ID: 11940567
[TBL] [Abstract][Full Text] [Related]
31. Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells.
Simon AR; Takahashi S; Severgnini M; Fanburg BL; Cochran BH
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1296-304. PubMed ID: 12003786
[TBL] [Abstract][Full Text] [Related]
32. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
33. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
34. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
35. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
36. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF.
Valdembri D; Serini G; Vacca A; Ribatti D; Bussolino F
FASEB J; 2002 Feb; 16(2):225-7. PubMed ID: 11744626
[TBL] [Abstract][Full Text] [Related]
37. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
[TBL] [Abstract][Full Text] [Related]
39. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
[TBL] [Abstract][Full Text] [Related]
40. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells.
Watanabe S; Mu W; Kahn A; Jing N; Li JH; Lan HY; Nakagawa T; Ohashi R; Johnson RJ
Am J Nephrol; 2004; 24(4):387-92. PubMed ID: 15256805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]